Authors:
PATTERSON MB
MACK JL
MACKELL JA
THOMAS R
TARIOT P
WEINER M
WHITEHOUSE PJ
Citation: Mb. Patterson et al., A LONGITUDINAL-STUDY OF BEHAVIORAL PATHOLOGY ACROSS 5 LEVELS OF DEMENTIA SEVERITY IN ALZHEIMERS-DISEASE - THE CERAD BEHAVIOR RATING-SCALE FOR DEMENTIA, Alzheimer disease and associated disorders, 11, 1997, pp. 40-44
Authors:
SANO M
ERNESTO C
KLAUBER MR
SCHAFER K
WOODBURY P
THOMAS R
GRUNDMAN M
GROWDON J
THAL LJ
BECKER RD
BENNETT D
BLASS J
CLARK CM
COTMAN CW
DAVIS KL
DEKOSKY S
DOODY RS
DRACHMAN D
FERRIS S
FOLSTEIN M
HOPKINS J
FOSTER N
HARRELL L
JARVIK L
KAYE J
KNOPMAN D
KUMAR V
MORRIS JC
PETERSEN RC
PFEIFFER E
RASKIND M
SCHMITT F
SCHNEIDER LS
STRITTMATTER W
TARIOT P
WEINER MF
WHITEHOUSE P
Citation: M. Sano et al., RATIONALE AND DESIGN OF A MULTICENTER STUDY OF SELEGILINE AND ALPHA-TOCOPHEROL IN THE TREATMENT OF ALZHEIMER-DISEASE USING NOVEL CLINICAL OUTCOMES, Alzheimer disease and associated disorders, 10(3), 1996, pp. 132-140
Authors:
WEINER MF
KOSS E
WILD KV
FOLKS DG
TARIOT P
LUSZCZYNSKA H
WHITEHOUSE P
Citation: Mf. Weiner et al., MEASURES OF PSYCHIATRIC-SYMPTOMS IN ALZHEIMER PATIENTS - A REVIEW, Alzheimer disease and associated disorders, 10(1), 1996, pp. 20-30
Citation: K. Frederiksen et al., MINIMUM DATA SET PLUS (MDS-SCALES() SCORES COMPARED WITH SCORES FROM 5 RATING), Journal of the American Geriatrics Society, 44(3), 1996, pp. 305-309
Authors:
MCDANIEL KD
EDLAND SD
HEYMAN A
HARRELL L
HENDERSON V
WIEDERHOLT WC
KARP H
EVANS DA
BENNETT DA
CLARK DB
BRANDT J
GROWDON J
FOSTER NL
MORTIMER J
MORRIS J
BLASS J
MAYEUX R
MOHS R
FERRIS S
TARIOT P
EARL NL
FRIEDLAND R
CLARK C
DEKOSKY ST
DOODY R
WEINER M
LARSON E
RASKIND M
BERG L
VANBELLE G
FILLENBAUM G
Citation: Kd. Mcdaniel et al., RELATIONSHIP BETWEEN LEVEL OF INSIGHT AND SEVERITY OF DEMENTIA IN ALZHEIMER-DISEASE, Alzheimer disease and associated disorders, 9(2), 1995, pp. 101-104
Citation: K. Frederiksen et al., COMPARISON OF SCORES FROM THE NEW-YORK-STATE MDS-HOME RESIDENT ASSESSMENT WITH SCORES FROM 5 RATING-SCALES( NURSING), The American journal of geriatric psychiatry, 2(3), 1994, pp. 262-262
Authors:
KIEBURTZ K
MCDERMOTT M
SHOULSON I
OAKES D
FAHN S
LANG A
PENNEY JB
RODNITZKY R
SHULTS C
TANNER C
TETRUD J
GORDON M
LEWITT P
BENNETT J
KOLLER W
FRIEDMAN JH
KURLAN R
OBRIEN C
MARK MH
WEINER WJ
SANCHEZRAMOS J
PAULSON G
COMELLA C
JANKOVIC J
OLANOW W
SHANNON K
LEWIS P
WINFIELD L
CIECIERSKI K
MISTURA K
LANDOW E
DIETRICH S
GEBHARDT AM
BARTER R
KENNEDY D
CULLEN KA
GARDINER IF
BERGEN M
PATTERSON V
FABRIELE M
SHELDON C
CORNELIUS L
DUDTE K
THELEN JA
DUNNE C
GAUGER L
MALAPIRA T
COURVILLE K
TROTTER H
PELUSIO RM
RUDOLPH A
CASACELI C
MILLER C
BOETTRICH C
CONNORTON J
BYRNE L
ORME C
BORDWELL K
MCMANUS J
SOTACK J
RANDOLPH H
KAVANAUGH B
BAKER D
RUMFOLA L
NOBEL R
EBERLY S
PLUMB S
WATTS A
GERWITZ K
DARCY S
EVANS P
FREDERICK D
DELLAPENA L
SINGLETARY V
TARIOT P
BELL E
GRIGGS RC
HALL WJ
HERNDON R
MARSDEN CD
CHASE TN
COHEN G
FLEISS J
JACOBS L
MOSS AJ
MELAMED E
DORFLINGER E
YOO K
SHIMOUN G
MORAWSKY L
Citation: K. Kieburtz et al., A CONTROLLED TRIAL OF LAZABEMIDE (RO-19-6327) IN LEVODOPA-TREATED PARKINSONS-DISEASE, Archives of neurology, 51(4), 1994, pp. 342-347